Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NXLthis companyNexalin Technology, Inc.	$1.43	-1.12×	2.44×	30.32×	-1.04×	-664.7%	79.7%	-2781.7%	-2725.8%	-219.4%	-223.9%	-54.2%	0×	0.08×	0×	4.85×	0.0%	3	-54.5	1	D+
HBIOHarvard Bioscience, Inc.	$9.07	-0.52×	2.16×	0.34×	-1.4×	-319.6%	53.0%	-0.7%	-65.5%	-412.8%	-1.0%	18.9%	3.22×	-0.77×	-0.13×	2.2×	0.0%	5	-2.53	1	D+
MODDModular Medical, Inc.	$1.70	-0.43×	0.93×	0×	-0.21×	36.8%	0.0%	0.0%	0.0%	-217.9%	-206.4%	-229.5%	0.03×	0.25×	0×	4.03×	0.0%	1	-14.77	3	B-
NRXSNeurAxis, Inc.	$6.32	-4.78×	12.13×	11.55×	-4.79×	-170.9%	84.2%	-219.4%	-218.5%	-229.5%	-204.7%	-15.7%	0.12×	0.59×	-105.85×	2.05×	0.0%	3	5	1	C-
RVPRetractable Technologies, Inc.	$0.58	-1.8×	0.31×	0.6×	-4.85×	32.4%	0.1%	-52.8%	-32.8%	-16.9%	-15.2%	-32.9%	0.01×	0.38×	-230.03×	6.57×	1.0%	2	0.88	2	C+
SCYXSCYNEXIS, Inc.	$3.56	-3.67×	0.64×	1.53×	-1.54×	-706.6%	100.0%	-78.0%	-41.8%	-17.4%	-29.9%	-16.7%	0.04×	2.35×	-92.91×	7.04×	0.0%	2	-5.05	2	C+
Peer median	—	-1.8×	0.93×	0.6×	-1.54×	-170.9%	53.0%	-52.8%	-41.8%	-217.9%	-29.9%	-16.7%	0.04×	0.38×	-92.91×	4.03×	0.0%	2	-2.53	2	—